Fidelity International’s Amicus Therapeutics FOLD Stock Holding History

Fidelity International’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,560,028	Closed	-$182M	–	1170
2026 Q1	$182M	Buy	12,560,028 +11,603,028	+1,212%	+$166M	0.14%	160
2025 Q4	$13.6M	Buy	+957,000	New	+$9.4M	0.01%	537

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Fidelity International's FOLD Position: Q2 2026 in Review

Fidelity International sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 12,560,028 shares — an estimated $182M sold.

Fidelity International first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $182M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Fidelity International reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Fidelity International sold 12,560,028 Amicus Therapeutics shares in Q2 2026, an estimated $182M.
Fidelity International first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Fidelity International's Amicus Therapeutics position peaked at $182M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.